CD5 pharmaceutical compositions for the treatment of infectious and inflammatory processes of fungal origin
US8404633B2 · kind B2 · utility
2Cited by
0References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 19, 2009 |
| Grant date | Mar 26, 2013 |
| Priority date | — |
| Expiry date | Jun 19, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention refers to pharmaceutical compositions comprising the soluble CD5 ectodomain and its use for the prevention and/or treatment of fungal infections and/or fungal sepsis, as well as inflammatory disorders of fungal origin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.